SWOT Analysis
- S
- W
- O
- T
Technical Analysis
Moving Averages
We appreciate your patience. Your content is on the way.
Current Price
- Bullish Moving Averages
- Bearish Moving Averages
Resistance and support
We appreciate your patience. Your content is on the way.
Company Financials
- Profit and loss statement
- Balance sheet
- Quarterly Result
- Ratio
We appreciate your patience. Your content is on the way.
Quick Results Snapshot
We appreciate your patience. Your content is on the way.
Stocks Comparison
Table
Chart
We appreciate your patience. Your content is on the way.
Corporate Action
- Announcement
- Board Meeting
- Dividend
- Split
- Rights
- Events
Insider & Institutional Activity
- Bulk Block Deals
- Insider Trading & SAST
We appreciate your patience. Your content is on the way.
About Oxygenta Pharmaceutical Ltd
Stock PE (TTM)
Promoter Holding
Book Value
ROCE
ROE
Oxygenta Pharmaceutical Limited was initially incorporated as S S Organics Private Limited as a private limited Company in 1990. The Company converted its status to a Public Limited Company in 1993 changing the name to S S Organics Limited. Further, it was changed to Oxygenta Pharmaceutical Limited in FY 2021-22. The Company was incorporated with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals. It manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and anti-inflammatory drugs. The Company has plant located at Medak in Andhra Pradesh. The Company is strong in manufacturing of anti ulcerative and anti bacterial drugs. The Company is doing contract manufacturing work for APL and also having its own production. Apart from these, it is doing contract manufacturing work with APL for manufacturing of Cirprofloxacin HCL from Q-Acid and has been manufacturing Pantaprozole Sodium and Gabapentine for own production. This contract manufacturing helped the Company to meet major operational expenses. Since the Company started commercial production in July, 2015 after fire accident tragedy, it is in process of stabilizing the manufacturing and marketing.
Oxygenta Pharmaceutical share price as on 10 Feb 2026 is Rs. 58.55. Over the past 6 months, the Oxygenta Pharmaceutical share price has decreased by 40.53% and in the last one year, it has decreased by 32.48%. The 52-week low for Oxygenta Pharmaceutical share price was Rs. 51.31 and 52-week high was Rs. 133.5.
524636
INE102E01018
Sep
Oxygenta Pharmaceutical Ltd FAQs
You can buy Oxygenta Pharmaceutical Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Oxygenta Pharmaceutical Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Feb 09, 2026 04:01 PM the closing price of Oxygenta Pharmaceutical Ltd was Rs.58.55.
The latest PE ratio of Oxygenta Pharmaceutical Ltd as of Feb 09, 2026 04:01 PM is -12.00
The latest PB ratio of Oxygenta Pharmaceutical Ltd as of Feb 09, 2026 04:01 PM is -5.90
The 52-week high of Oxygenta Pharmaceutical Ltd share price is Rs. 133.50 while the 52-week low is Rs. 51.31
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Feb 09, 2026 04:01 PM, the market cap of Oxygenta Pharmaceutical Ltd stood at Rs. 216.54 Cr.
Market Outlook
View allWe appreciate your patience. Your content is on the way.